Intrinsiqq
BriaCell Therapeutics Corp. logo

BriaCell Therapeutics Corp.

BCTX

Compare

Valuation & Multiples

Based on TTM earnings · Diluted shares

Market Cap$27M
EPS-$6.97
P/E-0.44
P/FCF-0.93
EV/EBITDA-0.17
FCF Yield–
Div. Yield–
Net Debt/FCF0.7x
BriaCell Therapeutics Corp. intrinsic value
52-Week Range
$2.74$9.01

Profitability & Returns

Revenue

N/A

Net Income (TTM)

-$35M

▼ -32.7% YoY

Op. Margin

–

ROIC

-173.18%

▲ +74.8pp YoY

Cash Flow & Balance Sheet

FCF (TTM)

-$29M

▼ -2.2% YoY

Op. Cash Flow (TTM)

-$29M

▼ -1.7% YoY

Net Debt

-$21M

Net Cash Position

Cash & Equiv.

$21M

Continue Research

Peers

Pharmaceutical Preparations · Pick stocks to compare with BCTX

CompareIntrinsic value
AMRNAmarin Corp PLC\Uk
$10.57-6.13%46
WVEWave Life Sciences Ltd.
$2.56-5.88%40
RLYBRallybio Corporation
$15.47-0.32%62
KNSAKiniksa Pharmaceuticals International, plc
$93.90+0.38%71
ESPREsperion Therapeutics Inc.
No recent price50
JNJJohnson & Johnson
$270.47+1.25%53
CELUCelularity Inc.
$0.46-1.88%0
CYDYCytoDyn Inc.
$0.22-3.43%0

BriaCell Therapeutics (BCTX) in two numbers

Dividend
None
No dividend in the SEC filings we hold.
Dividends
P/E
-0.44
Negative: a loss over the last twelve months. Price to free cash flow -0.93.
Financials

Questions about BriaCell Therapeutics

Does BriaCell Therapeutics (BCTX) pay a dividend?

No. BriaCell Therapeutics (BCTX) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.

Source: 10-Q filed 28 Oct 2026 (period ending 31 Jul 2026), SEC. Price: last close 20 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.

Spot a number that looks wrong? Check it in BCTX's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing BCTX

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.